Kepos Capital LP Neurocrine Biosciences Inc Transaction History

Kepos Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$83.82 - $101.5 $2.9 Million - $3.51 Million	-34,545 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$72.24 - $91.27 $1.43 Million - $1.81 Million	-19,794 Reduced 36.43%	34,545 $2.92 Million
Q3 2018 Nov 13, 2018	BUY	$98.88 - $125.85 $5.37 Million - $6.84 Million	54,339 New	54,339 $6.68 Million

625

95.2M

661K

227K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.